FDA Says Found Possible Carcinogen in Certain Samples of Merck's Januvia

The Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drug Januvia, were contaminated with a possible carcinogen.
Reuters Health Information

source https://www.medscape.com/viewarticle/978953?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?